Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users

Abstract Background SARS-CoV-2 reached Europe in early 2020 and disrupted the private and public life of its citizens, with potential implications for substance use. The objective of this study was to describe possible changes in substance use in the first months of the SARS-CoV-2 pandemic in Europe...

Full description

Bibliographic Details
Main Authors: Jakob Manthey, Carolin Kilian, Sinclair Carr, Miroslav Bartak, Kim Bloomfield, Fleur Braddick, Antoni Gual, Maria Neufeld, Amy O’Donnell, Benjamin Petruzelka, Vladimir Rogalewicz, Ingeborg Rossow, Bernd Schulte, Jürgen Rehm
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Substance Abuse Treatment, Prevention, and Policy
Subjects:
Online Access:https://doi.org/10.1186/s13011-021-00373-y
id doaj-edb2b79181fa44629e5bed0366c2d598
record_format Article
spelling doaj-edb2b79181fa44629e5bed0366c2d5982021-05-02T11:21:42ZengBMCSubstance Abuse Treatment, Prevention, and Policy1747-597X2021-04-0116111110.1186/s13011-021-00373-yUse of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance usersJakob Manthey0Carolin Kilian1Sinclair Carr2Miroslav Bartak3Kim Bloomfield4Fleur Braddick5Antoni Gual6Maria Neufeld7Amy O’Donnell8Benjamin Petruzelka9Vladimir Rogalewicz10Ingeborg Rossow11Bernd Schulte12Jürgen Rehm13Institute of Clinical Psychology and Psychotherapy, Technische Universität DresdenInstitute of Clinical Psychology and Psychotherapy, Technische Universität DresdenCenter for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE)First Faculty of Medicine and General Teaching Hospital Prague, Department of Addiction, Charles UniversityCentre for Alcohol and Drug Research, Aarhus UniversityClínic Foundation for Biomedical Research (FCRB)Clínic Foundation for Biomedical Research (FCRB)Institute of Clinical Psychology and Psychotherapy, Technische Universität DresdenPopulation Health Sciences Institute, Newcastle University, Baddiley-Clark BuildingFirst Faculty of Medicine and General Teaching Hospital Prague, Department of Addiction, Charles UniversityFirst Faculty of Medicine and General Teaching Hospital Prague, Department of Addiction, Charles UniversityNorwegian Institute of Public Health, Dept of Alcohol, Tobacco and DrugsCenter for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE)Institute of Clinical Psychology and Psychotherapy, Technische Universität DresdenAbstract Background SARS-CoV-2 reached Europe in early 2020 and disrupted the private and public life of its citizens, with potential implications for substance use. The objective of this study was to describe possible changes in substance use in the first months of the SARS-CoV-2 pandemic in Europe. Methods Data were obtained from a cross-sectional online survey of 36,538 adult substance users from 21 European countries conducted between April 24 and July 22 of 2020. Self-perceived changes in substance use were measured by asking respondents whether their use had decreased (slightly or substantially), increased (slightly or substantially), or not changed during the past month. The survey covered alcohol (frequency, quantity, and heavy episodic drinking occasions), tobacco, cannabis, and other illicit drug use. Sample weighted data were descriptively analysed and compared across substances. Results Across all countries, use of all substances remained unchanged for around half of the respondents, while the remainder reported either a decrease or increase in their substance use. For alcohol use, overall, a larger proportion of respondents indicated a decrease than those reporting an increase. In contrast, more respondents reported increases in their tobacco and cannabis use during the previous month compared to those reporting decreased use. No distinct direction of change was reported for other substance use. Conclusions Our findings suggest changes in use of alcohol, tobacco and cannabis during the initial months of the pandemic in several European countries. This study offers initial insights into changes in substance use. Other data sources, such as sales statistics, should be used to corroborate these preliminary findings.https://doi.org/10.1186/s13011-021-00373-yAlcoholTobaccoCannabisSubstance useEuropeCOVID-19
collection DOAJ
language English
format Article
sources DOAJ
author Jakob Manthey
Carolin Kilian
Sinclair Carr
Miroslav Bartak
Kim Bloomfield
Fleur Braddick
Antoni Gual
Maria Neufeld
Amy O’Donnell
Benjamin Petruzelka
Vladimir Rogalewicz
Ingeborg Rossow
Bernd Schulte
Jürgen Rehm
spellingShingle Jakob Manthey
Carolin Kilian
Sinclair Carr
Miroslav Bartak
Kim Bloomfield
Fleur Braddick
Antoni Gual
Maria Neufeld
Amy O’Donnell
Benjamin Petruzelka
Vladimir Rogalewicz
Ingeborg Rossow
Bernd Schulte
Jürgen Rehm
Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
Substance Abuse Treatment, Prevention, and Policy
Alcohol
Tobacco
Cannabis
Substance use
Europe
COVID-19
author_facet Jakob Manthey
Carolin Kilian
Sinclair Carr
Miroslav Bartak
Kim Bloomfield
Fleur Braddick
Antoni Gual
Maria Neufeld
Amy O’Donnell
Benjamin Petruzelka
Vladimir Rogalewicz
Ingeborg Rossow
Bernd Schulte
Jürgen Rehm
author_sort Jakob Manthey
title Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
title_short Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
title_full Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
title_fullStr Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
title_full_unstemmed Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users
title_sort use of alcohol, tobacco, cannabis, and other substances during the first wave of the sars-cov-2 pandemic in europe: a survey on 36,000 european substance users
publisher BMC
series Substance Abuse Treatment, Prevention, and Policy
issn 1747-597X
publishDate 2021-04-01
description Abstract Background SARS-CoV-2 reached Europe in early 2020 and disrupted the private and public life of its citizens, with potential implications for substance use. The objective of this study was to describe possible changes in substance use in the first months of the SARS-CoV-2 pandemic in Europe. Methods Data were obtained from a cross-sectional online survey of 36,538 adult substance users from 21 European countries conducted between April 24 and July 22 of 2020. Self-perceived changes in substance use were measured by asking respondents whether their use had decreased (slightly or substantially), increased (slightly or substantially), or not changed during the past month. The survey covered alcohol (frequency, quantity, and heavy episodic drinking occasions), tobacco, cannabis, and other illicit drug use. Sample weighted data were descriptively analysed and compared across substances. Results Across all countries, use of all substances remained unchanged for around half of the respondents, while the remainder reported either a decrease or increase in their substance use. For alcohol use, overall, a larger proportion of respondents indicated a decrease than those reporting an increase. In contrast, more respondents reported increases in their tobacco and cannabis use during the previous month compared to those reporting decreased use. No distinct direction of change was reported for other substance use. Conclusions Our findings suggest changes in use of alcohol, tobacco and cannabis during the initial months of the pandemic in several European countries. This study offers initial insights into changes in substance use. Other data sources, such as sales statistics, should be used to corroborate these preliminary findings.
topic Alcohol
Tobacco
Cannabis
Substance use
Europe
COVID-19
url https://doi.org/10.1186/s13011-021-00373-y
work_keys_str_mv AT jakobmanthey useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT carolinkilian useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT sinclaircarr useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT miroslavbartak useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT kimbloomfield useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT fleurbraddick useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT antonigual useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT marianeufeld useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT amyodonnell useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT benjaminpetruzelka useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT vladimirrogalewicz useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT ingeborgrossow useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT berndschulte useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
AT jurgenrehm useofalcoholtobaccocannabisandothersubstancesduringthefirstwaveofthesarscov2pandemicineuropeasurveyon36000europeansubstanceusers
_version_ 1721492350492999680